Coral reefs may look like colorful rocks, but they’re actually animals living in partnership with tiny plant cells. This remarkable symbiosis powers entire ocean ecosystems. In this episode, Dr. Biology chats with Professor Liza Roger, whose Arizona State University lab is home to corals, sea anemones, and even upside-down jellyfish. Together, they uncover the secrets of coral “superpowers,” the causes of bleaching, and how nanoscale medicines might help reefs fight stress. From the desert to the

A recap of my presentation to Britcham Brazil, 7 October 2025 This morning I had the privilege of presenting to a distinguished audience at the British Chamber of Commerce and Industry in Brazil (Britcham), as part of a webinar titled “Health Data Equity in Latin America in the Age of AI and Genomics.” I was […]

During the week of Sept. 30, 2025, we enjoy reports of wandering skunks, diverse fungi, and migrating birds. Phenology Coordinator Charlie Mitchell responds.

This podcast with speakers Tomas Hajek, Canada, Danella Hafeman, USA, Hanne Lie Kjærstad, Denmark, and host Luisa Klahn, Sweden, is part of the Congress Preview podcast series from ECNP. Longitudinal studies help scientists understand why the course and outcomes of bipolar disorder vary so widely. In this episode, the speakers discuss brain changes, cognitive impairments, and mobile sensing, sharing insights from large, multi-modal cohort studies. They highlight how early markers and modifiab...

The frenzy among Western companies to access China’s biotechnology innovation is remaking the landscape for cross-border dealmaking, with assets becoming more expensive and partnerships earlier and broader than ever before. That’s being driven by exceptional capital efficiency, access to patients and speed of development, said Frazier Life Sciences’ James Li on The BioCentury Show podcast. Among multinational companies, “every company has an army on the ground hunting for assets,” said Li, wh...

The Fika Crew invited Robin Zavod, PhD, Professor of Pharmaceutical Science at Midwestern University, Downers Grove Campus, and AACP President, to share her passion for recognizing and supporting the unique ways learners and colleagues perceive and process information.  It starts with caring and showing compassionate concern for the well-being and success of our students, colleagues, and patients. Compassionate pedagogy asks faculty and preceptors to move towards teaching and learning practices that

Steven Shein, MD, FCCM, is the Chief of Pediatric Critical Care at University Hospitals Rainbow Babies & Children’s Hospital in Cleveland, Ohio, and holds the Linsalata Family Distinguished Chair in Pediatric Critical Care and Emergency Medicine. He is also the Co-Director of the PICU Clinical, Basic & Translational Research Program and an Associate Director of the Pediatric Critical Care Medicine Fellowship program. His research focuses on critical bronchiolitis and long-term neuro-c...

Welcome to Episode 4. This is the next of our dives into husbandry and some associated health concerns, tips for evaluation, and discussion of physiology and how it relates to the husbandry needs. This episode we discuss substrate! Want to learn more about the Association of Reptile and Amphibian Veterinarians: arav.org

Send us a text Psychiatry's dark patterns know no borders. In this eye-opening conversation, Safa Asgari reveals his three-year journey through psychiatric treatment in Iran that mirrors the experiences of countless patients worldwide. What begins as a straightforward OCD diagnosis quickly spirals into a nightmare of polypharmacy and cascading misdiagnoses. After experiencing severe side effects from Prozac, Safa finds himself labeled with bipolar disorder, schizoaffective disorder, and ADHD...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Lars Petersen, President & Chief Executive Officer at FUJIFILM Biotechnologies.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Lars, covering: The difficult decision to leave Novo Nordisk and make the jump from one great company to another in Genentech/Roche. How leaving a Biogen site led him to step away from big pharma after

Send us a text In this episode of the Life Science Success Podcast my guest is James Piacentino, CEO of Thrive Genetics, Inc., a pioneering digital health startup focused on transforming addiction risk assessment through genetic and behavioral science. James brings a unique blend of entrepreneurial experience, technical expertise, and personal mission to develop innovative solutions that help healthcare providers manage dependency risk with unprecedented precision. 00:00 Introduction to Life...

AI & Low-Code Transformation in Biotech IT #biotechit #AIrevolution #lowcodetechnology In this episode, Kevin Dushney, a seasoned CIO with over eight biotech companies under his belt, shares invaluable insights into the rapidly changing landscape of biotech IT. Please visit our website to get more information: https://swangroup.net/ With the rising impact of AI and low-code tools, small biotech teams can now deliver more than ever before. Kevin discusses how these tools are reshaping w...

What would you do if you learned your DNA carried a mutation that gave you up to an 85% lifetime risk of breast cancer? That’s the impossible decision at the heart of Love, Danielle, the first scripted feature film to explore the very real struggles of living with a BRCA gene mutation. In this episode, we are joined by Devin Sidell, the film’s co-writer, producer, and lead actress, who brings her own BRCA1 journey to the screen, and Amy Byer Shainman, the BRCA Responder, a patient advocate and

Microfluidics has long promised to reshape diagnostics, drug discovery, and laboratory science. Microfluidics is about manipulating how tiny amounts of liquid move through channels no wider than a human hair; a "lab on a chip" diagnostic. Now imagine being able to 3D print those channels instead of painstakingly etching them. Paul Marshall, CEO of Rapid Fluidics, is working to improve the norm by applying additive manufacturing to the design and production of microfluidic systems. In this epi...

Moritz Gerstung (EMBL-EBI Group Leader, 2015-2021) speaks with Angus Lamond (EMBL Group Leader, 1987-1995), discussing his transition from physics to computational biology, driven by the complexities of biological systems. He highlights his work at EMBL-EBI, which focused on cancer genomes and tumour dynamics using next-generation sequencing and AI tools. Moritz emphasised the importance of open data access, citing EMBL's role in storing and sharing genomes. He noted the significant impact of AI in

Lykke Hinsch Gylvin shares how Boehringer Ingelheim’s innovative clinical trial designs bring therapies to patients faster.See www.mckinsey.com/privacy-policy for privacy information

We know that people act/react differently to pain. But why is it that some people can tackle high levels of pain, while others can't? What determines our ability to deal with pain - and what can we do ourselves to take control over our pain?

Hello! Welcome to the Neuroplasticity podcast, where I discuss how neuroscience research changed my life, all while my cat knocks things over and meows in the background in an attempt to ruin my life. Today's episode focuses on the importance of effective science communication at the academic, government, and social levels. Here, I delve into the realities of grant writing (especially in another language, cough cough Quebec), the challenges science faces in disseminating public knowledge, as well as

In this episode, we dive into the science behind Naturaz, a hair care brand built on vegan, non-GMO formulations. Mumbi Dunjwa, founder of Naturaz, discusses the company’s origin story and how Naturaz is reshaping the conversation around beauty, self-acceptance and sustainability. More on Naturaz can be found here.

Sickle cell disease was once considered an incurable disease, until recently. A wide variety of gene therapies have now become available, allowing patients with sickle cell disease to now have futures once thought unimaginable. In this podcast episode, we talk through these treatments and get expert advice on what these treatments mean for our future.